ArticleJournal of thoracic disease2023

Efficacy and safety of immune checkpoint inhibitors in lung large-cell neuroendocrine carcinoma.

Zheng Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.